Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the vyepti market grown in recent years?

In recent years, there has been an XX (HCAGR) expansion in the market size for Vyepti. It’s currently projected to grow from $XX million in 2024, to $XX million in 2025, showing a compound annual growth rate (CAGR) of XX%. Factors contributing to this growth in the past include a steady increase in chronic disease management, a rising demand for pain management medications, growing instances of target diseases, more investments in the biopharmaceutical sector, and a surge in home healthcare services.

How is the vyepti market size expected to evolve during the forecast period?

Over the next few years, it is predicted that the vyepti market will experience a XX (FCAGR), and by 2029, it is expected to attain a value of $XX million, marking a compound annual growth rate (CAGR) of XX%. This anticipated growth in the predicted period can be connected to various factors. This includes the shift towards personalized medicine, the rising growth of telemedicine, increased interest in wellness and self-care amongst consumers, a growing focus on preventive healthcare, as well as the adoption of biosimilars and generic drugs. Furthermore, the forecasted period indicates substantial trends such as innovation in the technologies utilized for drug delivery, advances made in drug formulation, the use of wearable devices for treatment monitoring, the implementation of AI and machine learning in making treatment decisions, and technological progress in drug manufacturing.

Get your vyepti market report here!

https://www.thebusinessresearchcompany.com/report/vyepti-global-market-report

Which key drivers are propelling the vyepti market’s growth?

The escalating occurrence of migraines is anticipated to fuel the expansion of the vyepti market in the future. Migraines are intense headaches often associated with symptoms such as nausea, throwing up, and hypersensitivity to light or sound. The occurrence of migraines is a result of an amalgamation of genetic, environmental, and lifestyle elements, including hormonal fluctuations, tension, sleep disruptions, and particular food-related instigators. Vyepti (eptinezumab) counteracts migraines by aiming at and restraining the CGRP (calcitonin gene-related peptide) protein, a crucial player in the formation of migraines, consequently diminishing the frequency and harshness of migraines. For instance, in October 2023, the Association of Migraine Disorders, a crucial US-based organization devoted to improving the comprehension and handling of migraines, stated that migraines influence roughly 1 in 7 individuals globally, with a conspicuously higher prevalence in females, evaluated at 17-19% in contrast to 5-7% in males. In the United States, over 35 million people suffer from migraines, with the majority being within the 35 and 45 age bracket. Thus, the escalating occurrence of migraines is catalyzing the expansion of the vyepti market.

What are the market segments in the vyepti industry?

The vyepti market covered in this report is segmented –

1) By Indication: Chronic Migraine; Episodic Migraine; Other Neurological Indications

2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

3) By End User: Adult; Geriatric

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20434&type=smp

Which leading companies are shaping the growth of the vyepti market?

Major companies operating in the vyepti market are H. Lundbeck A/S.

What key trends are currently impacting the vyepti market’s development?

A significant trend in the vyepti market can be seen in the emergence of novel treatments like the intravenous (IV) treatment for migraines, aimed at improving effectiveness and ease of use for the patient. The IV treatment for migraine entails dispensing medication via a vein for fast alleviation of intense migraine symptoms, commonly employed when oral drugs do not deliver results. For example, H. Lundbeck A/S, a pharmaceutical corporation hailing from Denmark, was granted approval by the European Commission in January 2022 for Vyepti (eptinezumab) in the European Union (EU), to be used as a preventive treatment against migraines in adults. Vyepti (eptinezumab) is a humanized monoclonal antibody that targets the calcitonin gene-related peptide (CGRP), a fundamental molecule implicated in migraine attacks, and is fashioned for IV administration, offering fast and sustained relief from migraine symptoms.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20434

Which geographic areas are influencing the growth of the vyepti market?

North America was the largest region in the vyepti market in 2024. The regions covered in the vyepti market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Migraine Treatment Global Market Report 2025

https://thebusinessresearchcompany.com/report/migraine-treatment-global-market-report

Migraine Global Market Report 2025

https://thebusinessresearchcompany.com/report/migraine-global-market-report

Migraine Drugs Global Market Report 2025

https://thebusinessresearchcompany.com/report/migraine-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: